Lorraine Comanor

1.2k total citations
22 papers, 922 citations indexed

About

Lorraine Comanor is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Lorraine Comanor has authored 22 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 18 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in Lorraine Comanor's work include Hepatitis B Virus Studies (19 papers), Hepatitis C virus research (17 papers) and Liver Disease Diagnosis and Treatment (7 papers). Lorraine Comanor is often cited by papers focused on Hepatitis B Virus Studies (19 papers), Hepatitis C virus research (17 papers) and Liver Disease Diagnosis and Treatment (7 papers). Lorraine Comanor collaborates with scholars based in United States, Canada and France. Lorraine Comanor's co-authors include David K. Shay, W. Thompson, Cathy A. Petti, Martin Petric, Paul V. Holland, Mel Krajden, David A. Hendricks, James M. Minor, Michel Friesenhahn and Chris Sherlock and has published in prestigious journals such as Journal of Clinical Microbiology, The Journal of Infectious Diseases and Journal of Hepatology.

In The Last Decade

Lorraine Comanor

22 papers receiving 880 citations

Peers

Lorraine Comanor
Preeyaporn Vichaiwattana Thailand
Cynthia Wat United Kingdom
Heidi Smuts South Africa
Jo McAnerney South Africa
Masayoshi Shinjoh Japan
Loreta A. Kondili Italy
Ariadna Rando‐Segura Spain
Tiansheng Xie China
Yee Leong Teoh Singapore
M S Ho Taiwan
Preeyaporn Vichaiwattana Thailand
Lorraine Comanor
Citations per year, relative to Lorraine Comanor Lorraine Comanor (= 1×) peers Preeyaporn Vichaiwattana

Countries citing papers authored by Lorraine Comanor

Since Specialization
Citations

This map shows the geographic impact of Lorraine Comanor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorraine Comanor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorraine Comanor more than expected).

Fields of papers citing papers by Lorraine Comanor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorraine Comanor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorraine Comanor. The network helps show where Lorraine Comanor may publish in the future.

Co-authorship network of co-authors of Lorraine Comanor

This figure shows the co-authorship network connecting the top 25 collaborators of Lorraine Comanor. A scholar is included among the top collaborators of Lorraine Comanor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorraine Comanor. Lorraine Comanor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jain, Mamta K., Lorraine Comanor, A. Clinton White, et al.. (2006). Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV‐coinfected patients: factors associated with response. Journal of Viral Hepatitis. 14(3). 176–182. 53 indexed citations
2.
Comanor, Lorraine & Paul V. Holland. (2006). Hepatitis B virus blood screening: unfinished agendas. Vox Sanguinis. 91(1). 1–12. 77 indexed citations
3.
Monto, Arnold S., Lorraine Comanor, David K. Shay, & W. Thompson. (2006). Epidemiology of Pandemic Influenza: Use of Surveillance and Modeling for Pandemic Preparedness. The Journal of Infectious Diseases. 194(s2). S92–S97. 31 indexed citations
4.
Martinot-Peignoux, Michelle, Lorraine Comanor, James M. Minor, et al.. (2006). Accurate model predicting sustained response at week 4 of therapy with pegylated interferon with ribavirin in patients with chronic hepatitis C. Journal of Viral Hepatitis. 13(10). 701–707. 12 indexed citations
5.
Thompson, W., Lorraine Comanor, & David K. Shay. (2006). Epidemiology of Seasonal Influenza: Use of Surveillance Data and Statistical Models to Estimate the Burden of Disease. The Journal of Infectious Diseases. 194(s2). S82–S91. 227 indexed citations
6.
Petric, Martin, Lorraine Comanor, & Cathy A. Petti. (2006). Role of the Laboratory in Diagnosis of Influenza during Seasonal Epidemics and Potential Pandemics. The Journal of Infectious Diseases. 194(s2). S98–S110. 127 indexed citations
7.
Aswad, S., et al.. (2005). Role of nucleic acid testing in cadaver organ donor screening: detection of hepatitis C virus RNA in seropositive and seronegative donors. Journal of Viral Hepatitis. 12(6). 627–634. 10 indexed citations
8.
Krajden, Mel, Annie Mak, Gail McNabb, et al.. (2004). Evaluation of the Core Antigen Assay as a Second-Line Supplemental Test for Diagnosis of Active Hepatitis C Virus Infection. Journal of Clinical Microbiology. 42(9). 4054–4059. 22 indexed citations
9.
Martinot‐Peignoux, Michèle, Lorraine Comanor, Corinne Castelnau, et al.. (2003). Early virologic response (EVR) at week 8 is more predictive of sustained response (SR) to pegylated combination therapy than at week 12. Journal of Hepatology. 38. 154–155. 1 indexed citations
10.
Comanor, Lorraine & David A. Hendricks. (2003). Hepatitis C virus RNA tests: performance attributes and their impact on clinical utility. Expert Review of Molecular Diagnostics. 3(6). 689–702. 1 indexed citations
11.
Khan, Nasreen, et al.. (2003). Improved detection of HCV Infection in hemodialysis patients using a new HCV RNA qualitative assay: experience of a transplant center. Journal of Clinical Virology. 30(2). 175–182. 19 indexed citations
12.
Friesenhahn, Michel, et al.. (2003). Performance Evaluation of the VERSANT HCV RNA Qualitative Assay by Using Transcription-Mediated Amplification. Journal of Clinical Microbiology. 41(1). 310–317. 28 indexed citations
13.
Hendricks, David A., et al.. (2003). Multicenter Evaluation of the VERSANT HCV RNA Qualitative Assay for Detection of Hepatitis C Virus RNA. Journal of Clinical Microbiology. 41(2). 651–656. 35 indexed citations
14.
Comanor, Lorraine, Mel Krajden, Kathryn E. Kronquist, et al.. (2002). Successful HCV genotyping of previously failed and low viral load specimens using an HCV RNA qualitative assay based on transcription-mediated amplification in conjunction with the line probe assay. Journal of Clinical Virology. 28(1). 14–26. 19 indexed citations
15.
16.
Comanor, Lorraine, James M. Minor, Hari S. Conjeevaram, et al.. (2001). Impact of chronic hepatitis B and interferon‐α therapy on growth of children. Journal of Viral Hepatitis. 8(2). 139–147. 40 indexed citations
17.
Comanor, Lorraine, Frank Anderson, Marc G. Ghany, et al.. (2001). Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment. The American Journal of Gastroenterology. 96(10). 2968–2972. 55 indexed citations
18.
Krajden, Mel, et al.. (1998). Multi‐measurement method comparison of three commercial hepatitis B virus DNA quantification assays. Journal of Viral Hepatitis. 5(6). 415–422. 33 indexed citations
19.
Habersetzer, François, Fabien Zoulim, Mary‐Anne Trabaud, et al.. (1998). Clinical evaluation of the branched DNA assay for hepatitis B virus DNA detection in patients with chronic hepatitis B lacking hepatitis B e antigen and treated with interferon‐α. Journal of Viral Hepatitis. 5(6). 407–414. 7 indexed citations
20.
Lau, Daryl, et al.. (1998). Statistical models for predicting a beneficial response to interferon‐α in patients with chronic hepatitis B. Journal of Viral Hepatitis. 5(2). 105–114. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Preeyaporn Vichaiwattana Breakdown of academic impact, for papers by Cynthia Wat Breakdown of academic impact, for papers by Heidi Smuts Breakdown of academic impact, for papers by Jo McAnerney Breakdown of academic impact, for papers by Masayoshi Shinjoh Breakdown of academic impact, for papers by Loreta A. Kondili Breakdown of academic impact, for papers by Ariadna Rando‐Segura Breakdown of academic impact, for papers by Tiansheng Xie Breakdown of academic impact, for papers by Yee Leong Teoh Breakdown of academic impact, for papers by M S Ho
Rankless by CCL
2026